Oxford Immunotec Global PLC Ordinary Shares
OXFD
OXFD was delisted on the 5th of March, 2021.
92 hedge funds and large institutions have $420M invested in Oxford Immunotec Global PLC Ordinary Shares in 2019 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 32 increasing their positions, 24 reducing their positions, and 11 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
91% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 11
39% more capital invested
Capital invested by funds: $303M → $420M (+$117M)
33% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 24
12% more funds holding
Funds holding: 82 → 92 (+10)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Senvest Management
New York
|
+$5.86M |
| 2 |
Fidelity International
Hamilton,
Bermuda
|
+$5.13M |
| 3 |
Morgan Stanley
New York
|
+$3.7M |
| 4 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$3.62M |
| 5 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$3.47M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
-$9.45M |
| 2 |
ECM
Endurant Capital Management
San Mateo,
California
|
-$5.68M |
| 3 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$4.17M |
| 4 |
RG
Redmile Group
San Francisco,
California
|
-$3.58M |
| 5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$1.5M |
OXFD Hedge Fund Activity: Q1 2019 in Review
92 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Oxford Immunotec Global PLC Ordinary Shares (OXFD) for Q1 2019, worth a combined $420M — up 39% from $303M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new OXFD positions and 11 closed out — a net gain of 10 holders — while 32 added to existing stakes and 24 trimmed.
The largest buyer was Senvest Management, opening a new position worth an estimated $5.86M. The largest seller was Alyeska Investment Group, cutting an estimated $9.45M.
- 92 institutional investors held Oxford Immunotec Global PLC Ordinary Shares (OXFD) as of Q1 2019, up from 82 in Q4 2018.
- Funds reported $420M of Oxford Immunotec Global PLC Ordinary Shares stock for Q1 2019, up 39% quarter-over-quarter.
- 21 funds opened new Oxford Immunotec Global PLC Ordinary Shares positions in Q1 2019 and 11 closed out, a net change of +10 holders.
- The largest Oxford Immunotec Global PLC Ordinary Shares buyer in Q1 2019 was Senvest Management, an estimated $5.86M added.
- The largest Oxford Immunotec Global PLC Ordinary Shares seller in Q1 2019 was Alyeska Investment Group, an estimated $9.45M sold.
Based on aggregated 13F filings for Q1 2019.